Copyright
©The Author(s) 2020.
World J Cardiol. Jun 26, 2020; 12(6): 269-284
Published online Jun 26, 2020. doi: 10.4330/wjc.v12.i6.269
Published online Jun 26, 2020. doi: 10.4330/wjc.v12.i6.269
Year | Number RHC | Types of arrhythmia | Incidence rate, n (%) | Setting | Study design | Procedural Outcomes | Ref. |
1979 | 73 | VA (> 1 PVCs in 4 beats) | 27 (36.9) | OR | Prospective | All self-limited | Shaw et al[58] |
Randomized | |||||||
1981 | 320 | Overall | 36 (16.4) | ICU | Prospective | 3 VTs: Treatment | Sise et al[20] |
VA not treatment | 33 (10) | Observational | |||||
VA required treatment | 3 (1) | ||||||
1981 | 60 | PVCs | 29 (48) | ICU | Retrospective | 2 VTs: Treatment | Sprung et al[56] |
VT | 20 (33) | Observational | 1 VF: Mortality | ||||
1982 | 107 | VT (> 3 cPVCs, > 150 pbm) | OR | Prospective | All self-limited | Salmenpera et al[60] | |
Lidocaine | 8/53 (15) | Randomized | |||||
Placebo | 10/54 (19) | ||||||
1982 | 150 | Advanced VA | 80 (53) | ICU | Prospective | 3 VTs: Treatment | Sprung et al[17,56] |
Salvos (3-5 cPVCs) | 45 (30) | Observational | 2 VFs: Mortality | ||||
NSVT (6-30 cPVCs) | 30 (20) | ||||||
VT (> 30 cPVCs) | 5 (3) | ||||||
VF | 2 (1.3) | ||||||
1983 | 67 | Advanced VA | 42 (63) | ICU | Prospective | All self-limited | Sprung et al[59] |
Lidocaine ppx | 18/31 (58) | Randomized | |||||
placebo | 24/36 (67) | ||||||
1983 | 528 | PVCs | 58 (11) | ICU | Prospective | 8 VTs: Meds | Boyd et al[21] |
VT | 8 (1.5) | Observational | |||||
VF | 0 | ||||||
1985 | 56 | Advanced VA | 7 (12.5) | ICU | Prospective | All self-limited | Iberti et al[22] |
Observational | |||||||
1985 | 250 | PVCs | 162/250 (64.8) | OR | Prospective | All self-limited | Damen et al[14] |
VT (> 3 cPVC > 100 bpm) | 11/250 (4.4) | Observational | |||||
VF | 0 | ||||||
1986 | 1400 | Overall | 880/1400 (62.9) | OR | Prospective | All self-limited | Damen et al[2] |
PVCs | 838/1400 (59.9) | Observational | |||||
VT (> 3 cPVC > 100 bpm) | 42/1400 (3) | ||||||
VF | 0 | ||||||
1986 | 142 | Overall | 64 (45) | ICU | Prospective | All self-limited | Patel et al[55] |
Benign (singlet PVCs) | 24 (16.9) | Observational | |||||
Malignant1 | 40 (28.1) | ||||||
1989 | 68 | Overall | 55 (80.9) | OR | Prospective | All self-limited | Keusch et al[57] |
Benign (1-2 PVCs) | 30 (44.1) | Observational | |||||
Malignant2 | 25 (36.8) | ||||||
2007 | 100 | PAC insertion | OR | Prospective | All self-limited | Gwak et al[13] | |
Overall | 70 (70) | Observational | |||||
Benign | 33 (33) | ||||||
Malignant3 | 37 (37) | ||||||
2012 | 139 | Overall | 76/139 (54.7) | OR | Prospective | All self-limited | Pipanmekaporn et al[28] |
Benign (1-2 PVCs) | 58 (41.7) | Randomized | |||||
Severe (≥ 3 PVCs) | 28 (20.1) | ||||||
2013 | 380 | VT | 0 | Hybrid CCL | Retrospective | DCCV | Bergmann et al[19] |
VF | 1 (0.26) | Observational | |||||
2017 | 174 | Overall | 149/174 (85.6) | OR | Prospective | All self-limited | Satol et al[23] |
Multiple PVCs ≥ 2 | 78/174 (44.8) | Observational |
- Citation: Shaik FA, Slotwiner DJ, Gustafson GM, Dai X. Intra-procedural arrhythmia during cardiac catheterization: A systematic review of literature. World J Cardiol 2020; 12(6): 269-284
- URL: https://www.wjgnet.com/1949-8462/full/v12/i6/269.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i6.269